ArticleUrology case reports2025
A master of disguise: A rare case of renal solitary fibrous tumour.
Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solitary fibrous tumour (SFT) of the kidney is extremely rare, with fewer than 100 reported cases. We describe a 58-year-old male with a left renal mass, initially suspected as transitional cell carcinoma on CT urography. He underwent radical nephroureterectomy with bladder cuff excision. Histology revealed spindle cells in a collagenous stroma, and immunohistochemistry showed strong nuclear STAT6 positivity, confirming SFT. Postoperative recovery was uneventful, and the patient remains disease-free at six months. Renal SFT diagnosis relies on histopathology and immunohistochemistry, with complete surgical excision as the mainstay and long-term surveillance recommended due to recurrence risk.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.